Symbol: |
SSSCA1
|
Description: |
Sjogren syndrome/scleroderma autoantigen 1 [Source:HGNC Symbol;Acc:11328]
|
Location: |
Chr11:65337901-65341413[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:164
Gene |
Compound |
Gen_sig |
Exp_pattern |
SSSCA1 |
NSC 26112 |
0.009 |
Down |
SSSCA1 |
NANAOMYCIN |
0.029 |
Down |
SSSCA1 |
NSC 294526 |
0.001 |
Down |
SSSCA1 |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.001 |
Down |
SSSCA1 |
NSC 295642 |
0.001 |
Down |
SSSCA1 |
Avarol |
0.007 |
Down |
SSSCA1 |
AI 3-63984 |
0.001 |
Down |
SSSCA1 |
3',4',5'-Trimethoxyflavone |
0.038 |
Down |
SSSCA1 |
1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide |
0.004 |
Down |
SSSCA1 |
ANTINEOPLASTIC-328785 |
0.008 |
Down |
SSSCA1 |
CHALCONE ANALOG |
0.001 |
Down |
SSSCA1 |
1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide |
0.037 |
Down |
SSSCA1 |
NSC 357777 |
0.021 |
Down |
SSSCA1 |
Piperidine, 2,6-diphenyl-1-methyl-4-[(phenylmethoxy)imino]-, cis- |
0.002 |
Down |
SSSCA1 |
ANTINEOPLASTIC-376265 |
0.016 |
Down |
Expression pattern: Sensitivity / Resistance
Total:11 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:1
SNP |
Gene |
SNP_location |
SNP_allele |
rs75303597 |
SSSCA1 |
Chr11:65339207 |
A/G |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:18
Total:2 Current:1
[First] [Prev]  Next Last 
|